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Enhancer RNAs (eRNAs) are a subset of long noncoding RNA generated from
genomic enhancers: they are thought to act as potent promoters of the expres-
sion of nearby genes through interaction with the transcriptional and epigenomic
machineries. In the present work, we describe two eRNAs transcribed from the
enhancer of Nkx2-5—a gene specifying a master cardiomyogenic lineage tran-
scription factor (TF)—which we call Intergenic Regulatory Element Nkx2-5 En-
hancers (IRENEs). The IRENEs are encoded, respectively, on the same strand
(SS) and in the divergent direction (div) respect to the nearby gene.Of note, these
two eRNAs have opposing roles in the regulation of Nkx2-5: IRENE-SS acts as a
canonical promoter of transcription, whereas IRENE-div represses the activity
of the enhancer through recruitment of the histone deacetylase sirtuin 1. Thus,
we have identified an autoregulatory loop controlling expression of the master
cardiac TF NKX2-5, in which one eRNA represses transcription.
INTRODUCTION
Cardiomyocyte (CM) homeostasis is critical for correct cardiac function: indeed, its impairment causes heart fail-
ure (Ross, 1983). Transcription factors (TFs) have long been known to orchestrate and control the pattern of gene
expression that underpins homeostasis in the CM (Saadane et al., 1999; Luna-Zurita et al., 2016). More recently,
long noncoding RNAs (lncRNAs), a class of transcripts >200 nucleotides in length but with a coding potential of
<100 amino acids, have been described playing important roles in defining the transcriptional programs of heart
development and pathophysiology (Papait et al., 2013b). For example, the lncRNAs Fendrr (FOXF1 adjacent
non-coding developmental regulatory RNA) (Grote et al., 2013) and Bvht (braveheart) (Klattenhoff et al., 2013)
control cardiac lineage commitment and embryonic heart development; the myosin heavy-chain-associated
RNA transcript Mhrt (myheart) is also required for correct CM functioning, with its downregulation involved in
pressure overload-induced cardiac remodeling (Han et al., 2014);Chaer (cardiac-hypertrophy-associated epige-
netic regulator) promotes the transcription of hypertrophic genes blocking polycomb repressor complex 2
(PRC2) (Wang et al., 2016); andMIAT (myocardial infarction associated transcript) acts as a pro-fibrotic lncRNA
in post-infarct myocardium (Qu et al., 2017).
Among the different types of lncRNAs controlling gene expression are enhancer RNAs (eRNAs), transcripts
derived from enhancer regions of the genome in a manner dependent on the activation of those regulatory
elements (Li et al., 2016). Enhancers generating abundant eRNAs, a characteristic of those comprised in
super-enhancers—regions densely occupied by TFs and other master regulators—promote an expression
of nearby genes higher than those that do not produce them (Kim et al., 2018). The control of gene activa-
tion by eRNAs is achieved via different mechanisms, including maintenance of chromatin accessibility for
RNA polymerase II (Mousavi et al., 2013), and interaction with the co-activator complex Mediator (Lai et al.,
2013) or with the cohesion complex (Hsieh et al., 2014) for enhancer-promoter loop maintenance. Despite
the importance of eRNAs, their role in the heart remains poorly explored.
Here, we describe two eRNAs transcribed from the enhancer of NK2 homeobox 5 (Nkx2-5)—which encodes
a master TF for cardiac development and pathophysiology (Pashmforoush et al., 2004; Saadane et al., 1999;iScience 23, 101539, September 25, 2020 ª 2020 The Authors.





ArticleBruneau et al., 2000; Delaughter et al., 2016)—with antagonistic regulatory effects on transcription of the
target gene. These two eRNAs, which we have called Intergenic Regulatory Element Nkx2-5 Enhancers
(IRENEs), are encoded from the same strand (SS) and from the divergent direction (div). Of note, IRENE-
SS acts as a canonical promoter of Nkx2-5 transcription, whereas IRENE-div represses the activity of the
enhancer by recruiting the histone deacetylase (HDAC) sirtuin 1 (SIRT1). Experiments on human induced
pluripotent stem cells (hiPSCs) revealed that the two human homologs are regulated during cardiac differ-
entiation in vitro. Our findings demonstrate the existence of an epigenetic mechanism involving an autor-
egulatory loop in which the transcription of a TF is controlled by the balance of eRNAs stemming from its
own gene’s enhancer.
RESULTS
The Nkx2-5 Enhancer Encodes Two eRNAs
To study the role of eRNAs in the heart, we first identified in mouse cardiomyocytes (CMs) any potential eRNAs
conserved in humans. To that end, we analyzed RNA sequencing (RNA-seq) datasets generated from CMs iso-
lated from adult mouse left ventricle (Greco et al., 2016; Rosa-Garrido et al., 2017) (Figure 1A). We found 112,286
lncRNAs (FPKM>0.1) inmouse, 4,127of whichwere expressedalso inmyocardial tissue fromninehealthy human
donors (Liu et al., 2019) and in hiPSC-derived CMs at day 15 of differentiation. Selecting only those lncRNAs
located in intergenic regions, we found 2,318 associated with a nearby protein-coding gene, 132 of which
were enriched in heart. After cross-checking these with three datasets of cardiac enhancers (Wamstad et al.,
2012; Papait et al., 2013a; Dickel et al., 2016), 46 were deemed putative eRNAs (Figure S1A). This set of putative
eRNAswas associatedwith 26 protein-codinggenes related tomuscle tissuemorphogenesis, cardiac cell devel-
opment, and apoptosis, as revealed by gene ontology (GO) enrichment analysis (Figure S1B).
We focused subsequent investigation on two putative eRNAs (IRENE-SS and IRENE-div) encoded, respectively,
on the positive and the negative DNA strand of the enhancer involved in regulating expression ofNkx2-5 (Lien
et al., 1999) (Figure 1B). The eRNAs were validated by northern blotting and through the mapping of their tran-
scription start sites (TSSs) using 50 rapid amplification of cDNA ends (50 RACE) analysis (Figure S2A).
To characterize IRENE-SS and IRENE-div, we first assessed their expression with respect to that ofNkx2-5 in 13
different adultmouse tissues and four sorted cardiac cell populations (CMs, fibroblasts, endothelial cells, and im-
mune cells). Quantitative PCR (qPCR) revealed that both had CM-specific expression (Figures S2B and S2C). Ab-
solutequantificationat three stagesof heartmaturation (E14.5, neonatal, andadult) revealed that theyweremore
highly expressed at the neonatal stage, but at differing ratios with respect toNkx2-5 (Figure S3A).
The function of a lncRNA is tightly related to its intracellular localization (Chen, 2016; Fazal et al., 2019). Thus, we
assessed the subcellular distribution of the eRNAs through cellular fractionation (Figure S3B) andRNA-FISH (Fig-
ure S3B): 60%of IRENE-SSwas located in the nucleus, 45%ofwhichbound to chromatin, whereas the localization
of IRENE-div was dependent upon the stage of the transcript’s biogenesis, with the mature form located prev-
alently in the cytoplasm and the immature form having a subcellular localization similar to that of IRENE-SS.
These results were suggestive of potential involvement of both eRNAs in chromatin organization.
Evolutionary selection is an important challenge in the study of lncRNAs because some diverge rapidly
(Amaral et al., 2008), in some cases with purifying selection at the sequence level and in other cases with
selection only for transcription (Chen et al., 2016). Therefore, we evaluated human orthologs with the Tran-
script-Transcript Identity (TTI) score (Chen et al., 2016) for each transcript in the syntenic genomic locus: we
found the TTI scores on TSSs to be 45% and 64% for IRENE-SS and IRENE-div (Figure S3C). Moreover, by
validating the expression of the eRNAs and that of the target gene in hiPSCs at different days of CM dif-
ferentiation, we found that the expression of both transcripts closely followed that of Nkx2-5 (Figure S3D).
Thus, the Nkx2-5 enhancer transcribes two putative cardiac-specific eRNAs whose expression follows that
of the nearby gene in mouse and humans.
IRENE-SS Activates and IRENE-div Represses Transcription of Nkx2-5
Since eRNAs regulate the expression of neighboring protein-coding genes (Kim et al., 2018), we investi-
gated the role of the IRENE transcripts in regulating the expression of Nkx2-5. To that end, primary
neonatal mouse CMs were transfected with gapmeRs synthesized to specifically silence either one of the
two eRNAs and then Nkx2-5 expression was analyzed 24 and 48 h after transfection. qPCR revealed that
silencing IRENE-SS reduced Nkx2-5 at the mRNA (34%) and protein (49%) levels, whereas silencing2 iScience 23, 101539, September 25, 2020
Figure 1. Identification of IRENE-SS and IRENE-div and Their Regulation of Nkx2-5
(A) Bioinformatics workflow for the discovery of conserved cardiac-enriched lncRNAs in adult mouse cardiomyocytes. PC,
protein coding.
(B) Schematic representation of IRENE-div (red) and IRENE-SS (blue) with genomic enhancer elements, transcription start
sites (TSSs) reported as a 50 RACE product, and stranded cardiomyocyte total RNA-seq from Greco et al. (2016) and Rosa-
Garrido et al. (2017).
(C) Relative expression of IRENE-SS, IRENE-div, and Nkx2-5 after gapmeR silencing specific for either one of the two
eRNAs compared with a negative control (scramble, scr) in primary cultures of neonatal cardiomyocytes at two different
time points (24 and 48 h). In blue, knockdown (KD) of IRENE-SS; in red, KD of IRENE-div. Silencing of IRENE-SS decreased
Nkx2-5 mRNA; in contrast, silencing of IRENE-div increased Nkx2-5 mRNA.





ArticleIRENE-div caused an increase ofNkx2-5 at both levels (mRNA, +31%; protein, +84%) (Figures 1C and S1C).
Thus, the two eRNAs had opposite effects on Nkx2-5 transcription: IRENE-SS functioned as a transcrip-
tional activator, whereas IRENE-div acted as a transcriptional repressor.
To verify whether the biological effects of the eRNAs were mainly due to their ability to regulate Nkx2-5
expression, we analyzed the impact of their silencing on global gene expression, determining whether
the changes were related to modifications in the activity of TFs. To that end, we first compared the expres-
sion profile of neonatal CMs transfected with the gapmeRs versus that of CMs transfected with a scrambled




Articlerespectively (Figure S4A). Then, we determined the enrichment of putative NKX2-5 targets versus targets of
two other cardiac TFs: TBX5 and GATA4. Since these TFs regulate transcription through binding to en-
hancers as well as promoters (Akerberg et al., 2019), we considered as putative targets all genes mapping
to chromatin immunoprecipitation (ChIP) peaks on both those regulatory elements, using a published
ChIP-seq dataset (Luna-Zurita et al., 2016). The overlap between genes modulated by IRENE-div or
IRENE-SS silencing and the datasets of putative targets of the three TFs analyzed revealed that the
most enriched modulated genes were indeed NKX2-5 targets (Figure S4B): specifically, 43.6% (N =
1,108) and 43.8% (N = 1,205) of genes were modulated by depletion of IRENE-SS and IRENE-div,
respectively. Moreover, GO analysis revealed that pathways related to cardiac muscle development and
ion transmembrane transporter activity were specifically associated with genes repressed by the silencing
of IRENE-SS and genes increased after the silencing of IRENE-div (Figure S4C), a finding coherent with our
previous observations on the opposing effects of the eRNAs on Nkx2-5.
Then, to assess whether the effect of IRENE-SS on gene expression was specifically dependent upon its
ability to regulate Nkx2-5, we tested if overexpression of NKX2-5 rescued correct gene expression in
CMs with knocked-down IRENE-SS. To this end, neonatal CMs were transfected with a gapmeR targeting
IRENE-SS andwith a construct for NKX2-5 overexpression and then analyzed 24 h later with qRT-PCR for the
expression of six NKX2-5-targeted genes identified by ChIP-seq. We found that overexpression of NKX2-5
was not sufficient to restore correct expression of the analyzed genes (Figure S5). The absence of a rescued
phenotype could be explained by the fact that the eRNA acted on those genes independently of the level
of NKX2-5, although we cannot exclude that the overexpression obtained was not sufficient to correct the
transcriptional changes.
IRENE-SS Promotes Transcription by Recruiting NKX2-5 to Regulatory Sequences
Because IRENE-SS had two key characteristics of an eRNA—transcription from an enhancer and transcrip-
tional promotion of the neighboring gene—we evaluated the impact of its silencing on the activity of the
enhancer, analyzing the distribution of two histone modifications: H3K27ac, which marks active enhancers,
and H3K27me3, which defines poised enhancers (Shlyueva et al., 2014). ChIP assay coupled with qPCR
(ChIP-qRT-PCR) (see Figure 2A for the location of the primers used throughout this work) revealed that
IRENE-SS silencing decreased H3K27ac on the enhancer, without interfering with H3K27me3 (Figure 2B).
Since NKX2-5 promotes its own transcription (Clark et al., 2013), and many eRNAs participate in enhancer-pro-
moter loop formation (Wang et al., 2011; Arner et al., 2015; Sigova et al., 2015), we assessed whether IRENE-SS
promoted the recruitment of NKX2-5 to its own promoter/enhancer regions. First, we determined if there was a
physical association between IRENE-SS and NKX2-5. An RNA immunoprecipitation (RIP) assay on HL1 cells, an
immortalized CM line, carried out with antibodies targeting NKX2-5 indicated that the TF bound IRENE-SS but
not IRENE-div (Figure 2C). Moreover, in vitro RNA pull-down followed by immunoblotting using a biotinylated
sense or antisense RNA fragment of IRENE-SS confirmed precipitation of NKX2-5 with the antisense RNA (Fig-
ure 2D). Then, we tested the binding of NKX2-5 protein to its own genomic regulatory regions (promoter and
enhancer) in neonatal CMs after silencing of IRENE-SS: ChIP-qRT-PCR revealed decreasedNKX2-5 binding after
silencing (Figure 2E). Thus, IRENE-SSworks as a canonical eRNA, promoting the transcription ofNkx2-5 through
the recruitment of NKX2-5 to its own promoter and enhancer.
IRENE-div Silences the Nkx2-5 Enhancer by Recruiting SIRT1
The above results indicated that IRENE-div repressed Nkx2-5 transcription. This finding was supported by
the analysis of H3K27ac and H3K27me3 on the regulatory regions of the Nkx2-5 gene after silencing of the
eRNA with a gapmeR in neonatal CMs: indeed, ChIP-qRT-PCR revealed that IRENE-div silencing enriched
H3K27ac at the enhancer of Nkx2-5, whereas the level of H3K27me3 did not change (Figure S6A).
Since IRENE-div bound chromatin and its silencing increased histone acetylation, we tested the hypothesis that
the eRNA controlled the transcription of Nkx2-5 through recruitment of HDACs. To that end, we examined in
neonatal CMs and quiescent skeletal muscle satellite cells the genomic distribution of the enzymes as reported
in published ChIP-seq datasets (Ai et al., 2017; Ryall et al., 2015). We found that the HDACs SIRT1 and HDAC2
were enriched at the Nkx2-5 enhancer (Figure S6B). Binding of those HDACs to the enhancer of the TF’s gene
was then validated in HL1 cells with ChIP-qRT-PCR: as expected, antibodies targeting either SIRT1 or HDAC2
immunoprecipitated theNkx2-5 enhancer region (Figure S6C). However, RIP performedwith antibodies against
SIRT1 and HDAC2 showed significant enrichment of IRENE-div in the SIRT1 immunoprecipitate versus negative4 iScience 23, 101539, September 25, 2020
Figure 2. IRENE-SS Acts via the Binding and Recruitment of NKX2-5 to Its Own Regulatory Region
(A) Location of primers used in this work.
(B) ChIP-qRT-PCR was conducted on neonatal cardiomyocytes. Silencing of IRENE-SS was associated with reduced H3K27ac on the enhancer region
(primers 1, 2, and 3) and no effect on H3K27me3, with the exception of primer 2. Values are expressed as fold enrichment over scrambled gapmeR (scr)-
treated cells. N = 3 biological replicates (Student’s unpaired t test).
(C) RNA immunoprecipitation (RIP) assay conducted on HL1 cells demonstrating biochemical interaction of NKX2-5 with IRENE-SS but not with IRENE-div or
the control gene Gapdh. Interaction is expressed as enrichment over input. N = 3 different experiments (one-way ANOVA with Sidak post hoc test).
(D) In vitro RNA pull-down revealed an association of NKX2-5 with the RNA fragment of IRENE-SS after SDS-PAGE and immunoblotting. IN, input; IP,
immunoprecipitate; AS, antisense; S, sense.
(E) ChIP-qRT-PCR performed on neonatal cardiomyocytes after IRENE-SS knockdown (KD), showing a reduction of NKX2-5 enrichment at its promoter
(primer 4) and enhancer (primers 5 and 2). Values are expressed as fold enrichment over scr-treated cells of N = 3 biological replicates (Student’s unpaired t
test).
Data are represented as mean G SD. *p value <0.05; **, p value <0.01; ***, p value <0.001.
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Figure 3. IRENE-div Acts as a Transcriptional Repressor through Recruitment of SIRT1
(A) RNA immunoprecipitation performed on HL1 cells, using antibodies against SIRT1, showing that immature (I) and mature (M) forms of IRENE-div, but not
IRENE-SS or Gapdh mRNA, bind SIRT1. Interaction is expressed as enrichment over input in N = 3 different experiments (one-way ANOVA with Sidak post
hoc test).
(B) In vitro RNA pull-down revealed an association of SIRT1 with the RNA fragment of IRENE-div after SDS-PAGE and immunoblotting. IN, input; IP,
immunoprecipitate; AS, antisense; S, sense.
(C) ChIP-qRT-PCR conducted on HL1 cells after silencing of IRENE-div (red bars) compared with scrambled gapmeR-treated cells (gray bars). Antibodies
against SIRT1, H4K16ac, and H4, and three primers (1, 2, and 3) designed on the genomic enhancer element were used. Knockdown (KD) of IRENE-div
ll
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decreased SIRT1, with a consequential increase in H4K16ac, the histone modification produced by that enzyme. H4 immunoprecipitation was used as
control. Values are fold enrichment over scr-treated cells. N = 2 biological replicates (Student’s unpaired t test).
(D) Immunofluorescence in HL1 cells treated with RNAse A. Untreated cells were used as control. Nuclei stained with DAPI (blue); nuclear periphery stained
with lamin B (green); SIRT1 visualized in red (scale bars, 10 mm). Dot plots of the quantification of the immunofluorescence signal normalized for nuclear area
revealed loss of the SIRT1 signal after RNAse A treatment, a finding confirmed by western blotting.




Articlecontrol (IgG immunoprecipitate), indicating that IRENE-div bound SIRT1 but not HDAC2 (Figures 3A and S6D).
This interaction was not observed for IRENE-SS. RNA pull-down confirmed that SIRT1 precipitated with the
sense RNA but not with an antisense one (Figure 3B).
Next, to verify whether the above interaction was necessary for recruitment of SIRT1 to the enhancer, we as-
sessed the amount of the HDAC and one of its substrates, histone H4 acetylated at lysine 16 (H4K16ac), at
this genomic region after silencing IRENE-div in HL1 cells. ChIP-qRT-PCR revealed that silencing decreased
the level of the HDAC and increased H4K16ac deposition at the enhancer region (Figure 3C), suggesting that
IRENE-div promoted the transcriptional repression of Nkx2-5 through the recruitment of SIRT1. This finding
was confirmed in primary cultures of neonatal mouse CMs (Figure S6E). Furthermore, when HL1 cells were
treated with RNase A, which digests single-stranded RNA, SIRT1 became unbound from chromatin (Figure 3D),
suggesting that RNA was needed tomaintain this HDAC in the nucleus and that IRENE-divwas at least partially
responsible for local binding at the enhancer region under study.Polymer Model Simulation Reveals Alteration in 3D Chromatin Conformation
The above findings indicated that IRENE-SS and IRENE-div evoked antagonistic effects on the activity of
the Nkx2-5 enhancer through modulation of the epigenetic signature at this regulatory region. However,
chromatin architecture represents a higher order of organization with respect to the epigenetic landscape.
Therefore, we tested the hypothesis that the eRNAs and the histone marks modulated by their silencing
also modified the chromatin architecture at the enhancer. To that end, we modeled the 3D structure of
theNkx2-5 locus, using a computational inference approach based on the Strings & Binders (SBS) polymer
model of chromatin (Bianco et al., 2018). In an SBS model, a filament of chromatin is represented as a
coarse-grained chain of beads with binding sites for diffusing molecular binders (Figure 4A). A detailed
description of the theoretical model is reported in the Methods section.
Specifically, we focused on a 200-kb locus aroundNkx2-5 (chr17:26740000–2694000, mm10) and used published
Hi-C data onmouse CMs at 5-kb resolution (Rosa-Garrido et al., 2017) to derive a 3Dmodel of the locus. The Hi-
C experimental contact frequencymatrix was well reproduced by themodel contactmatrix, as indicated by their
high Pearson’s (r) and distance-corrected (r’) correlations (Figure 4B). 3D reconstruction of the genomic region
revealed, in general, a spatial proximity of the enhancer to the promoter through a loop formation (Figure 4C).
The derived polymer model for theNkx2-5 locus included 15 different types of binding sites (genomic locations
given in Figure 4D). To get insights into theirmolecular nature, we evaluated their correlationwith availableChIP-
seq peaks of histonemarks (H3K4me3, H3K9ac, H3K27ac, H3K79me2, andH3K27me3 in Papait et al., 2013a) (Pa-
pait et al., 2013a) and the CCCTC-binding factor (CTCF) (Rosa-Garrido et al., 2017). We found that each binding
site type had a specific, combinatorial pattern of positive andnegative correlations (Figure 4D). Since silencingof
IRENE altered acetylation at the enhancer, we tested in silico the impact of the eRNAs on locus folding by
rendering inert the binding sites associated with H3K27ac in the two 5-kb bins containing the ncRNAs/enhancer
region. Then, we re-computed the model contact matrix and compared it with the experimental control Hi-C.
Notably, the correlation decreased (Dr’ = r’(wt)-r’(silenced)) in the silenced model versus wild-type in the Nkx2-
5 topologically associating domain (green region), with Dr’ significantly different from that in a control model
in which we silenced all other possible bin pairs within the region (Figure 4E), excluding bins containing sites
for CTCF, a protein known to affect chromatin architecture (Fudenberg et al., 2016). These findings indicated
there was a rearrangement of locus architecture after silencing of the eRNAs. In particular, the model predicted
a loss of contact of30% between the Nkx2-5 gene and its enhancer compared with the wild-type (Figure 4F).DISCUSSION
eRNA was identified as a class of lncRNA able to promote transcription (Kim et al., 2010). Here, we show
that two eRNAs—namely, IRENE-SS and IRENE-div, both encoded from the same enhancer regioniScience 23, 101539, September 25, 2020 7
Figure 4. Polymer Modeling of the Nkx2-5 Locus Predicts that eRNA Silencing Impacts 3D Chromatin
Conformation
(A) Representation of the Strings & Binders polymer model, with the chromatin filament represented as a string of beads,
some of which are binding sites for diffusing molecular binders. Different types of binding sites interacting with specific
cognate binders are represented with different colors; non-interacting, inert beads are represented in gray.
(B) Hi-C contact matrix (top triangle) of the Nkx2-5 locus is well reproduced by the SBS-derived contact matrix (bottom
triangle) (Pearson correlation coefficient, r = 0.97; distance-corrected correlation, r’ = 0.75). In the bar in the middle, the
color scheme used is that of the 3D polymer representation given in (C).
(C) Examples of SBS-derived 3D structures of the locus, with relevant elements indicated by colored beads: Nkx2-5 gene
(red), enhancer (blue), and eRNA (green). The 3D structures highlight that promoter and enhancer tend to colocalize,
albeit with an intrinsic structural variability in the general architecture.
(D) Genomic location and abundance of the different types of binding sites inferred for theNkx2-5 locus. The different types are
represented in different colors (left) and are found to correlate with specific combinations of chromatin marks (right).
(E) Impact of eRNA silencing on 3D architecture at the locus. The binding sites associated with acetylation were made
inert (gray) at the eRNA and enhancer regions (left diagram). The distance-corrected correlation with Hi-C of the silenced
model contact matrix (orange box) is significantly lower than the wild-type (blue box). **, p value <0.01.
(F) Subtraction map between the silenced and wild-type model contact matrices. Red and blue indicate gain and loss of
contacts upon in silico silencing of acetylated binding sites at the enhancer/ncRNA region. Note that most of the contact
changes are located in the Nkx2-5 topologically associating domain (TAD; green). The dashed box highlights the
predicted loss of contacts between Nkx2-5 and the enhancer.
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Articleupstream from the TSS of the Nkx2-5 gene—have opposing effects on the regulation of the nearby gene:
IRENE-SS acts as a classical eRNA promoting the transcription of its target gene, whereas IRENE-div is an
unusual eRNA that functions as a transcriptional repressor. Here, we describe the differential molecular ef-
fects generated by two eRNAs transcribed from opposite strands of a genomic enhancer, and of how the
activity of a gene’s enhancer, namely, that of Nkx2-5, depends on the balance of the two eRNAs; indeed,
specific disruption of each one of the eRNAs produced contrasting effects on the transcription of Nkx2-5.
The locusof theenhancerunder studywasoriginally describedbyE.N.Olsonandcolleagues: theydemonstrated
theoverlappingof its activitywithNkx2-5expressionduring cardiogenesis and found that it is composedof three
partshavingdifferent roles in the regulationofNkx2-5geneexpression (Lienetal., 1999).More indetail, a seriesof
genomic deletions were used to define two activating regions separated by a negative regulatory segment
driving the transcription ofNkx2-5 during cardiogenic specification.Our findings elucidate themechanismof ac-
tion of this enhancer. The upstreamportion of the tripartite enhancer encodes IRENE-SS. This lncRNA positively
regulates Nkx2-5 expression by promoting, on the one hand, the acetylation of H3K27 needed for chromatin
looping, permitting the interaction between the enhancer and the promoter, and on the other the recruitment
of NKX2-5 to both the enhancer and the promoter. Our findings also support the conclusion that the auto-reg-
ulatory loopofNkx2-5 ismediated by eRNAsgenerated in the proximity of the gene’s locus and that the binding
ofNKX2-5protein to chromatindependsnot onlyon thepresenceof a specificbindingmotif but alsoon its direct
interactionwith theeRNAs.Although it hasbeenalready reported that RNAs stabilizeTFson regulatoryelements
of a gene (Sigova et al., 2015), our findings describe how this stabilization takes place at the Nkx2-5 locus.
RNA FISH experiments identified several nuclear sites where these lncRNAs were present, leading us to not
exclude the possibility that IRENE-SS and IRENE-div acted also in trans. For IRENE-SS, we can speculate
that, aside from recruiting NKX2-5 to its own gene’s enhancer, it is needed also for proper localization
of the TF at other regulatory regions it targets. However, overexpression of NKX2-5 in neonatal CMs
knocked-down for IRENE-SS did not restore the correct expression of selected analyzed target genes.
The absence of direct phenotypic rescue suggests that IRENE-SS could regulate gene expression through
mechanisms other than the regulation ofNkx2-5 expression. Indeed, IRENE-SS could recruit NKX2-5 to the
Nkx2-5 enhancer as well as to other regulatory regions targeted by the TF. However, we cannot exclude
that the level and timing of NKX2-5 overexpression we used were not ideal to obtain a rescued phenotype.
Moreover, we were not able to determine how the direct effect on chromatin architecture induced by
altered enhancer acetylation status impacted additional, indirect transcriptional changes. Further investi-
gations are needed to resolve these aspects.
In contrast, IRENE-div acts as a transcriptional repressor, recruiting the HDAC SIRT1. Indeed, the silencing of
IRENE-divwas associatedwith increased acetylation of the enhancer anddecreasedbindingof SIRT1 to this reg-
ulatory region. SIRT1 has been shown to regulate NKX2-5 at the protein level (Tang et al., 2016). Our findings
support also a role for this HDAC as a silencer ofNkx2-5’s enhancer. This, together with the nuclear solubilization
of SIRT1 after digestion with RNase A, suggests a role for RNA in stabilizing the binding of HDACs to chromatin.
However, the mechanism by which IRENE-div anchors SIRT1 to chromatin remains to be defined.
The importance of TF balance and cooperation for correct heart development and CM homeostasis is already
known (Luna-Zurita et al., 2016; Akerberg et al., 2019). Our work strongly supports the notion that eRNAs in-
teracting with critical TFs also contribute to the complex network of TF activity necessary for the CM specifi-
cation program. Of note, we have demonstrated not only the existence of the two eRNAs in human cells but
also that they are expressed in conjunction with that of the nearby Nkx2-5 gene during hiPSC differentiation
toward the CM lineage in vitro. Although further investigation is needed to establish the molecular role in hu-
man CMs, the relatively high sequence identity and conservation of the genomic locus between human and
mouse suggests the existence of similar functional orthologs in humans.Limitations of the Study
The absence of an animal model is a limitation of our study. Indeed, we focused our efforts to under-
standing the molecular mechanism of the two transcripts at the cellular level. An in vivo study could
generate other important information on the physiological and pathophysiological importance of these
two eRNAs in the heart. Further study is also needed to document the function of the human ortho-
logs in order to verify and confirm the relevance of the transcripts in human cardiomyocyte






Further information and requests for resources and reagents should be directed to and will be fulfilled by
the Lead Contact, Gianluigi Condorelli (gianluigi.condorelli@hunimed.eu).
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All unique/stable reagents generated in this study are available from the Lead Contact with a completed
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been deposited to Mendeley Data: https://doi.org/10.17632/25cnynmzx6.1. The accession numbers for
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Figure S1. Identification of IRENE-SS and IRENE-div Upstream of Nkx2-5, Related to Figure 1 
(A) Venn diagram of the overlap between the identified lncRNAs and three enhancer datasets (Papait et al., 2013a; Wamstad 
et al., 2012; Dickel et al., 2016). 
(B) Enriched biological processes obtained through gene ontology (GO) analysis of the 26 protein-coding genes associated 
with 46 putative eRNAs. NKX2-5 is associated with muscle tissue morphogenesis, ventricular cardiac muscle cell 
development, and regulation of cardiac muscle cell apoptotic processes. 
(C) Western blot showing downregulation of NKX2-5 after knockdown (KD) of IRENE-SS. Cells were collected 48 h after 
gapmeR transfection. Scr, scrambled gapmeR; KD-SS, gapmeR targeting IRENE-SS;  KD-div, gapmeR targeting IRENE-div.  
 
 
Figure S2. Characterization of IRENE-SS and IRENE-div Upstream of Nkx2-5 in Mice, Related to Figure 1 
(A) 5' RACE product and Northern blotting for IRENE-SS and IRENE-div, the latter in its two forms (immature/unspliced and 
mature). 
(B) qRT-PCR analysis of Nkx2-5, IRENE-div, and IRENE-SS in 13 different mouse tissues revealed enrichment in four 
different cardiac districts. 
(C) IRENE transcript expression in sorted adult heart cell populations (cardiomyocytes, fibroblasts, endothelia and immune 
cells), revealing cardiomyocyte-specific enrichment. CM, cardiomyocyte. 
Data represented as mean  SD. *, P-value <0.05; **, P-value <0.01; ***, P-value <0.001.  
 
Figure S3. Expression of IRENE-SS and IRENE-div Upstream of Nkx2-5 in Mice and Humans, Related to Figure 1 
(A) Expression of Nkx2-5 and IRENE transcripts measured by ddPCR at 3 different cardiomyocyte maturation stages: 
embryonic day 14.5, neonatal day p1, and 8-week-old adult mice. The table indicates the ratio between the copies of IRENE 
and the nearby gene (Nkx2-5) at the three different stages, and the graph shows expression reported as copies/l. 
(B) HL1 cell fractionation (nucleus, chromatin, and cytoplasm, as indicated by the different shades) (top) and RNA-FISH 
(bottom) assessing intracellular localization of IRENE transcripts: IRENE-SS and immature IRENE-div were 60% in the 
nucleus and mostly chromatin bound, whereas mature IRENE-div was 60% in the cytoplasm. Gapdh, U6, and Xist were used 
as RNA controls for the 3 different compartments. Bars = 10 µm. 
(C) Transcript-Transcript Identity scores showing the percentages of identity between mouse and human transcripts. 
(D) Nkx2-5, IRENE-SS, and IRENE-div expression in human iPSCs at 12 different time points during cardiomyocyte 
differentiation (N=2). 
Data represented as mean  SD.  
 
 
Figure S4. Differential Regulation of Nkx2-5 by IRENE-SS and IRENE-div, Related to Figure 1 
(A) Heatmap of differentially expressed genes for each gapmeR treatment (FDR 0.1; log CPM 0). 
(B) Bar chart of significant overlaps between genes associated with three TFs (NKX2-5, GATA4, and TBX5) and those 
modulated upon knockdown of either IRENE-SS or IRENE-div. Many more modulated genes were targets of NKX2-5 rather 
than of the other two TFs evaluated. The Venn diagram gives the number of modulated genes that were NKX2-5 targets. 
(C) Enriched biological process gene ontology (GO) terms for genes up- and down-regulated by silencing IRENE-SS or 
IRENE-div, respectively. The analysis reveals that highlighted terms are oppositely regulated by the silencing of IRENE-SS 
or IRENE-div, confirming the opposing effects mediated by the two eRNAs on NKX2-5 target genes. 
 
Figure S5. IRENE-SS Acts on NKX2-5 Target Genes Independently of NKX2-5 Level, Related to Figure 1 
For the six NKX2-5 target genes analysed, overexpression of NKX2-5 increased expression, whereas knockdown of IRENE-
SS caused a decrease. However, the overexpression of NKX2-5 in neonatal cardiomyocytes with knocked-down IRENE-SS 
did not restore correct expression of the genes. Scr, scramble-treated cells (transfected with a control vector and the control 
gapmeR); over, cells treated with an NKX2-5 overexpression vector; gap, cells treated with gapmeR targeting IRENE-SS; 
O+G, cells treated with the combination of overexpression vector and gapmeR targeting IRENE-SS. 
Data represented as mean  SD. *, P-value <0.05; **, P-value <0.01; ***, P-value <0.001 (one-way ANOVA with Sidak post 
hoc test).  
 
Figure S6. IRENE-div Recruits Histone Deacetylase to the Nkx2-5 Enhancer and its Reduced Impact on Acetylation 
Status, Related to Figure 3 
(A) ChIP−qRT-PCR conducted on neonatal cardiomyocytes revealed an enrichment of H3K27ac on the enhancer region 
(significant with primer 2) upon IRENE-div silencing, with no effect on methylation (H3K27me3). Values are expressed as 
fold enrichment on scr-treated cells. N=3 biological replicates. 
(B) Cardiomyocyte ChIP-seq tracks of HDAC2 and SIRT1 from published datasets on neonatal CMs (neo CM) and skeletal 
muscle satellite cells (SCs) (Ai et al., 2017; Plimpton, 1995), showing peaks at the enhancer locus. 
(C) Validation of ChIP-seq peaks from published datasets of two deacetylases − SIRT1 (green) and HDAC2 (yellow) − 
through ChIP−qRT-PCR performed on HL1 cells using primers 2 and 3 on the enhancer element. 
(D) RIP performed on HL1 cells, using antibodies against HDAC2, showing that immature and mature forms of IRENE-div 
do not bind HDAC2. Interaction is expressed as enrichment over input in N=3 different experiments (one-way ANOVA with 
Sidak post hoc test). I, immature form; M, mature form. 
(E) ChIP−qRT-PCR conducted on neonatal cardiomyocytes after silencing of IRENE-div (red bar) compared with scrambled 
gapmeR-treated cells (grey bar). We used the antibodies against H4K16ac and H4, and three primers (1, 2, and 3) designed 
on genomic enhancer elements. Knockdown of IRENE-div led to a decrease in the enrichment of SIRT1 and a consequential 
increase in H4K16ac, the histone modification mark induced by SIRT1, whereas no change was detected in the control (H4 
immunoprecipitation). Values are expressed as fold enrichment over scr-treated cells. N=2 biological replicates (Student’s 
unpaired t-test). 
Data represented as mean  SD. *, P-value <0.05; **, P-value <0.01; ***, P-value <0.001.  
 
TRANSPARENT METHODS 
Annotation, Identification, and Conservation of lncRNAs and eRNAs 
Adult mouse cardiomyocyte RNA-seq data (from GSE66847 and GSE96690), human RUES2 cells, iPSC-derived CMs at 
day 15 of differentiation, and myocardial tissue from nine healthy humans (from GSE130036) were mapped using HISAT2 
(Kim et al., 2019) and aligned against GRCm38 and GRCh38 for mouse and human samples, respectively. BAM files with 
aligned paired-end reads were split into two strand-specific BAM files using SAMtools (Li et al., 2009). The properly paired 
reads originating from each strand were selected using SAM Flags 99 and 147 for one strand, 83 and 163 for the other strand. 
Forward (Fw) and reverse (Rw) strand was assigned according to the dUTP method used for sequencing. The transcript 
assembly was performed on each strand-specific BAM file, using StringTie (Pertea et al., 2015) with parameters -s 2 -g 100 
for lncRNA identification. The potential transcripts identified were unified using StringTie –merge with parameters -T 0 -F 
0, according to each set of replicated biological data. Transcripts with FPKM <0.1 were subsequently excluded using 
FPKM_count.py module from RSeQC software (Wang et al., 2012). Slncky (Chen et al., 2016), with default parameters, was 
used to predict the orthologous transcripts in human samples (hiPSC-derived CMs and healthy human myocardial tissue). 
Only orthologues identified in both datasets were considered. Three published enhancer datasets (Papait et al., 2013a; 
Wamstad et al., 2012; Dickel et al., 2016) were used to select the putative eRNAs, identified as lncRNAs that overlapped with 
enhancer genomic regions. The overlap between genomic regions was performed with IntersectBed (Quinlan and Hall, 2010). 
The list of 26 protein-coding genes associated with the eRNAs was then analysed using the online tool Enrichr (Kuleshov et 
al., 2016) to identify GO enrichments. The presented combined score (c) represents the multiplication of the p-value (Fisher 
exact test) and the z-score (z) of the deviation from the expected rank (c=log(𝑝)·𝑧; for more details, see: 
http://amp.pharm.mssm.edu/Enrichr/. 
Mouse RNA-sequencing 
Three biological replicates of neonatal primary CM cultures for each specific gapmeR treatment were profiled. DNase I-
treated RNA analysed on the Tape Station 4200 (Agilent) showed an RNA integrity number (RIN) of 9.7−9.8. SMART-seq 
v4 Ultra Low Input RNA Kits (Takara Bio) were used for cDNA amplification. Indexed sequencing libraries were generated 
using Nextera XT DNA Library Preparation Kits (Illumina) following the manufacturer’s instructions. Electrophoresis of the 
libraries on a LabChip GX instrument showed average library size of 500−555 bp. Single-end multiplexed libraries were 
sequenced using a NextSeq500 instrument. 19−34 million reads/sample were obtained. Single-end reads of 75 bp were aligned 
to the GENCODE Mus musculus reference genome (build GRCm38/mm10) using STAR v2.7.2b (Dobin et al., 2013). Raw 
read counts were normalized with TMM implemented in edgeR (Robinson et al., 2010); differential expression analysis of 
read counts was performed using glmQLFit and glmQLFTest functions. Significant differential genes were chosen based on 
an FDR ≤0.1 and logCPM ≥0. Hierarchical clustering of significantly modulated genes was performed using hclust and dist 
R functions (R Core Team, 2019). Clustering was performed with complete linkage method and Euclidean distance to generate 
a heatmap using pheatmap (Kolde, 2019). 
Human RNA-sequencing 
One biological replicate of human RUES2 cells and one of iPSC-derived CMs at day 15 of differentiation were profiled. 
DNase I-treated RNA analysed on the LabChip GXT (PerkinElmer) had RIN >7. Indexed sequencing libraries were generated 
using TruSeq Stranded Total RNA LT with Ribo-Zero Human/Mouse/Rat (Illumina), following the manufacturer’s 
instructions. Electrophoresis of the libraries on a LabChip GXT instrument showed an average library size of 311bp. Paired-
end multiplexed libraries were sequenced using the NextSeq500 instrument. 96−104 million reads for each sample were 
obtained. 
Nkx2-5, Tbx5, and Gata4 Gene Analysis 
Nkx2-5, Tbx5, and Gata4 average footprints obtained from in vitro differentiated mouse CMs (GSE72223) were used. Only 
ChIP-seq peaks that fell on gene promoters (−3kb/+2kb from the TSS) and/or enhancer genomic regions were selected. The 
NKX2-5, TBX5, and GATA4 target gene sets were identified using rGreat (Gu, 2019), using “oneClosest” rule and 
“adv_oneDistance = 500” to associate the selected regions to the nearby gene. Fisher test R function was used to test the 
significant overlap between modulated genes obtained from RNA-seq of the IRENE-SS and IRENE-div knockdown and the 
TF’s associated targets identified. GO enrichment analysis was performed with enrichR (Jawaid, 2019) and, using pheatmap, 
we plotted the raw z-score computed by centring and scaling the “enrichR combined scores”. RNA-seq data has been 
deposited in the NCBI GEO database (GSE143930, GSE143929). 
Primary Cardiomyocyte Culture 
Primary CMs were isolated from 1-day-old pups with the Neonatal Heart Dissociation Kit (Miltenyi). Cells were cultured in 
M-199, DMEM, 1% penicillin/streptomycin (Pen-Strep, 10000 U/ml), 1% ultraglutamine, 10% horse serum, and 5% foetal 
bovine serum (FBS).  
 
 
HL1 Cell Culture 
HL-1 cells, a mouse atrial CM immortalized cell line, were grown in Claycomb Medium (Sigma-Aldrich) supplemented with 
10% FBS (Sigma-Aldrich), 1% Pen-Strep, 1% ultraglutamine (200 mM), and 1 mM norepinephrine (Sigma-Aldrich) on 
gelatin/fibronectin pre-coated flasks. After reaching full confluence, cells were split according to Dr. Claycomb’s instructions 
(Claycomb et al., 1998).  
GapmeR Silencing and NKX2-5 Overexpression 
Transfections were carried out using standard Lipofectamine 2000 (ThermoFisher) protocols. GapmeR silencing was 
performed using 100 nM of scrambled, anti-IRENE-SS, or anti-IRENE-div sequences (QIAGEN). Cells were harvested after 
24 h and 48 h for qRT-PCR, 48 h for Western blotting, and 24 h for ChIP−qRT-PCR. The antisense LNA GapmeR standard 
sequences were: scr negative control A 5'-3': AACACGTCTATACGC; anti-IRENE-SS 5'-3': GAAGGTGATAATTTGA; and 
anti-IRENE-div 5'-3': TTCGGGTCAAGAGTGC. 
Overexpression was conducted using 250 ng of Nkx2-5 overexpression pcDNA3 vector. The rescue experiment was 
performed combining the transfection of 100 nM of gapmeR anti-IRENE-SS and 250 ng of overexpression vector in neonatal 
cardiomyocytes or the same amount of scrambled gapmeR and empty control vector. Cells were collected after 24 h and 
processing for qRT-PCR. 
Human Induced Pluripotent Stem Cell-derived Cardiomyocytes 
An erythroid body-based protocol was used to generate functional cardiomyocyte-like cells from feeder-free female and male 
hiPSCs. Human samples were collected after written informed consent by the patients. The expression of markers typical of 
pluripotent cells and karyotype was used to control cell lines, as described elsewhere (Di Pasquale et al., 2013). hiPSCs were 
differentiated using the monolayer differentiation protocol as described elsewhere (Salvarani et al., 2019). In brief, iPSCs 
were treated with 12 µM CHIR99021 and 5 µM IWR and cultured until they started to spontaneously beat. 
The following twelve different stages of hiPSC-CMs differentiation were used for the experiments: days 0, 1, 2, 3, 5, 6, 7, 9, 
10, 11, 13, and 15. Two sets of differentiation experiments were used and merged. RNA was extracted, retro-transcribed, and 
used for qRT-PCR. The primer sequences for the gene expression analyses were: 
hNKX2-5: Fw GAGCCGAAAAGAAAGCCTGAA, Rw CACCGACACGTCTCACTCAG; 
hIRENE-div: Fw GACATCACCCTCCCATTCCT, Rw AGAGTCATCTCCAGGGCTACC; 
hIRENE-SS: Fw GGCAGACCCCACACTTCA, Rw TTCCACGCTTGTTCAGTGC. 
Sorting of Pure Cardiomyocytes and Heart Cell Populations 
To isolate pure CM populations, we used a constitutively active CM-specific tdTomato reporter mouse (MHC 
Cre/+;R26tdTomato) that expresses Cre recombinase protein under control of the alpha myosin heavy chain (MHC) promoter 
(Abel et al., 1999) in addition to a loxP site-dependent tdTomato reporter within the ubiquitous Rosa26 gene locus, in the 
C57BL/6J background (Larcher et al., 2018). Cells were sorted to isolate CMs (Tom+), fibroblasts (CD45−/PDGF+), 
endothelial cells (CD45−/CD31+), and leukocytes (CD45+). All experiments were performed according to the 2010/63/EU 
Directive and approved by the ethics committee of Humanitas Research Hospital. 
RNA Preparation 
RNA was extracted using PureZOL isolation reagent (BioRad), following the manufacturer’s instructions, for mouse tissues, 
Northern blotting, and RIP. The Zymo Extraction Kit (EuroClone), plus DNAse treatment on columns, was used for RNA-
seq, qRT-PCR, and ddPCR. 
Quantitative RT-PCR 
RNA was retro-transcribed using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) for gene 
expression, and the SuperScript Vilo cDNA Synthesis Kit (Invitrogen) for fractionation and RIP. qRT-PCR was performed 
using the SYBR Green PCR Master Mix (Applied Biosystems). Primers used were: 
IRENE-SS: Fw CGTTTATGCTGTAGCGCTGT, Rw CTTGGGGCTGTGATTGATTT; 
IRENE-div (immature): Fw AGCATGAAGGAGCGTGACTT, Rw GTGCAGGTACAGGGGTTGTT; 
IRENE-div (mature): Fw AGGACCTTGTTACTGGCACTG, Rw TGTCTGTCTTTCTGTCTGGAGAA. 
Hprt was used to normalize Ct values, and the 2-𝛥Ct method and fold change were conducted to analyse data. 
Droplet Digital PCR 
The QX200 ddPCR system (BioRad) and an EvaGreen-based assay were used. The PCR reaction mix was loaded into 96-
well plates in an automated droplet generator. The plate was sealed, placed in the thermal cycler, and after the PCR reaction 
put into the droplet reader, experimental details set using QuantaSoft (BioRad), and the reading started. Data analysis was 
performed using QuantaSoft and values expressed as copies/l. 
 
RNA-Fluorescent in-situ hybridization (FISH) 
Custom Stellaris FISH probes were designed against IRENE-SS and IRENE-div by utilizing the Stellaris RNA FISH Probe 
Designer (Biosearch Technologies) available online at www.biosearchtech.com/stellarisdesigner (version 4.2). HL1 and 
HEK293 cells were hybridized with the IRENE-SS and IRENE-div Stellaris RNA-FISH probe set labelled with TAMRA-C9 
and QUASAR 670 dye, respectively (Biosearch Technologies), following the manufacturer’s instructions available online at 
www.biosearchtech.com/stellarisprotocols. Briefly, the cells were fixed with 3.7% formaldehyde and permeabilized 1 h at 
4°C with 70% ethanol. The coverslips were washed and hybridized overnight at 37°C in Hybridization Buffer with 2l of 
specific probe (stock solution: 12.5 M). The coverslips were then washed, stained with DAPI, and mounted on slides using 
one drop of FluorSave Reagent (Millipore). 
Cell Fractionation 
HL1 cells were collected in phosphate-buffered saline (PBS) and lysed in Cytoplasm Buffer (50 mM Tris-HCl [pH 8.0], 140 
mM NaCl, 1.5 mM MgCl2, 0.5% NP-40) supplemented with RNAsin (Promega) for 10 min on ice. After centrifugation at 
500 rpm for 5 min, the supernatant was collected as the cytoplasmic fraction. The remaining pellet was washed in 1X PBS 
and resuspended in Nucleoplasm Buffer (50 mM Tris-HCl [pH 8.0], 500 mM NaCl, 1.5 mM MgCl2, 0.5% NP-40) 
supplemented with RNAsin for 10 min on ice. Chromatin was pelleted at maximum speed for 5 min. Supernatant was collected 
as the nucleoplasm and the chromatin pelleted in 1X PBS. RNA from cytoplasmic and nucleoplasm fractions were precipitated 
using C2H3NaO2. RNA was extracted using the Zymo Kit supplemented with DNAse. The Super Script VILO cDNA 
Synthesis Kit (Invitrogen) was used to retro-transcribe RNA, with ddPCR to quantify target genes. 
Chromatin Immunoprecipitation 
For ChIP−qRT-PCR, cells were crosslinked in 1% formaldehyde and lysed to prepare nuclear extracts. Chromatin was 
sonicated to an average length of 200–300 bp using a Bioruptor Pico (Diagenode), clarified, precleared for 1 h, and 
immunoprecipitation performed at 4°C overnight with protein G Dynabeads (Invitrogen) coupled with the following 
antibodies (2 g for histone modification, 10 g for transcription factor and HDAC): anti-H3K27ac (ab4729, Abcam), anti-
H3K27me3 (07-449, Millipore), anti-H4 (ab10158, Abcam), anti-H4K16ac (17-10101, Millipore), anti-NKX2-5 (sc-8697, 
Santa Cruz), anti-SIRT1 (ab12193, Abcam), anti-HDAC2 (ab7029, Abcam). The washes were made in Buffer I (1 mM EDTA, 
0.1% SDS, 10 mM Tris HCl [pH 8.0], 140 mM NaCl, 0.1% sodium deoxyxholate, 1% Triton X-100), Buffer II (1 mM EDTA, 
0.1% SDS, 10 mM Tris HCl [pH 8.0], 500 mM NaCl, 0.1% sodium deoxyxholate, 1% Triton X-100), Buffer III (1 mM EDTA, 
10 mM Tris HCl [pH 8.0], 250 mM LiCl, 0.5% sodium deoxycholate, 0.5% NP-40), and Tris-EDTA (pH 8.0). Crosslinking 
was reverted overnight in Elution Buffer (5 mM EDTA, 10 mM TrisHCl [pH 8.0], 300 mM NaCl, 0.5% SDS) shaking at 
65°C. Proteinase K treatment for 2 h shaking at 45°C. DNA was extract with phenol:chloroform extraction. Primer sequences 
for ChIP−qRT-PCR were: 
ChIP_1: Fw GCCATTCGCTCCTAGCTTC, Rw GGGCAGTGACTCTTGGACTC; 
ChIP_2: Fw CCTCGCTCCAGTCAAACTTC, Rw CCACACAGCAGAGGGTTTGT; 
ChIP_3: Fw ACTTTGGAAGGGGAGAGGAG, Rw GGAAGTGGAGCAGTTGAAGC; 
ChIP_4: Fw TCTCTGCCCTGGATGTGG, Rw CCCCTACTCCAGCCTGCTC; 
ChIP_5: Fw CTGTCCTTCGCGTTCCTG, Rw AGTGACCCGCTCCATGTC; 
Ctrl: Fw GTAGATGGGATGGGTCATGG, Rw TGCTTTGAGGTTGCTTTGTG. 
Western Blotting 
Cells were washed with PBS and lysed in NP-40 lysis buffer (50 mM Tris, 150 mM NaCl, 0.5% NP-40, 2 mM EDTA, 100 
mM NaF, 10 mM sodium pyrophosphate) containing Protease Inhibitor Cocktail (Roche) and 1 mM phenylmethylsulfonyl 
fluoride. Protein concentrations were determined by the Bradford assay and 30 µg of total protein was resolved on SDS-
PAGE and blotted onto nitrocellulose (BioRad) for 1 h. Non-specific binding sites were blocked using 5% milk in PBS-
Tween. Membranes were incubated with primary antibodies overnight at 4°C in 5% bovine serum albumin in PBS. Primary 
antibodies were: anti-Nkx2-5 (1:500; Santa Cruz), anti-lamin B (1:500; Santa Cruz), anti-tubulin (1:2000, Abcam), and anti-
Sirt1 (1:1000, Millipore). Membranes were incubated with the HRP-conjugated secondary antibody (donkey anti-goat-HRP, 
goat anti-rabbit-HRP, goat anti-mouse-HRP, 1:2000 in 5% milk-PBS-T) for 1 h at room temperature. Protein was detected 
with Enhanced Chemiluminescence Western Blotting Substrate (Immobilon). 
Northern Blotting 
RNA was extracted using PureZOL isolation reagent (BioRad) and mixed in a 1:1 ratio with RNA sample loading buffer, 
boiled for 6 min at 70°C, and run on 1% agarose gel (1X MOPS buffer, 1% formaldehyde) in 1X MOPS buffer at 70 V for 3 
h. The gel was subsequently transferred to a positively charged nylon membrane in 20X SSC buffer by standard capillary 
transfer overnight. RNA was crosslinked to the membrane using UV fixation at 200 mJ for 3 min. Membrane was pre-
hybridized in NorthernMax Pre-hybridization/Hybridization Buffer for 3 h at 60°C. Membranes were incubated overnight 
with DIG-conjugated probes diluted in Hybridization Buffer at 60°C. Membranes were then washed in Northern blot low 
 
stringency buffer (3 times, 10 min/wash) at 60°C, followed by washes in Northern blot high stringency buffer (3 times, 10 
min/wash) at 60°C, and one wash in 1X PBS-Tween at room temperature for 5 min. Membranes were blocked in 1% blocking 
solution in 1X PBS-T (Roche) for 30 min at room temperature and then incubated with α-DIG-HRP secondary antibody 
(1:2000) for 1 h at room temperature. Membranes were washed 3 times in 1x PBS-Tween at room temperature, and RNA 
visualized using enhanced chemiluminescence. 
RNA Immunoprecipitation 
For RIP, HL1 cells were crosslinked using 150 mJ UV irradiation, washed in 1X PBS, scraped, and collected by centrifugation 
at 1000 rpm for 5 min. The cell pellet was lysed in RIP lysis buffer (25 mM Tris-HCl [pH 7.4], 150 mM KCl, 5 mM EDTA, 
0.5% NP-40, 0.5 mM DTT, protease inhibitors, and RNA inhibitor) on ice for 30 min. Lysate was centrifuged at 15,000 rpm 
for 10 min to remove cell debris, and incubated for 1 h (rotating, 4°C) with 50 µL protein-G magnetic beads (washed 3 times 
in 1X PBS) for pre-clearing. Pre-cleared lysate was then incubated overnight with previously conjugated antibody-protein-G-
bead complexes (beads incubated with 10 g primary antibody overnight at 4°C, rotating). Bead-antibody-lysate complexes 
were washed three times in 1X PBS, and RNA eluted with 300 l PureZOL isolation reagent (BioRad), followed by classical 
RNA extraction. 
RNA Pull-down 
RNA pull-down was performed as described elsewhere (Yamazaki et al., 2018). Briefly, a portion of IRENE-SS or IRENE-
div was cloned into the pBlueScript II KS (+) vector, and sense or antisense RNAs were synthetized using MAXIscript 
(Thermo Fisher Scientific) with T7 or T3 RNA polymerase, respectively, and DNase I. RNAs were precipitated with 
ammonium acetate/ethanol and subsequently biotinylated using the Pierce RNA 3′ End Biotinylation Kit (Thermo Fisher 
Scientific). HL1 cell extract (CE) was prepared using Cell Extraction Buffer (Thermo Fisher Scientific) following the 
manufacturer’s instructions. The CE was precleared with 50 l of Dynabeads M-280 Streptavidin (Thermo Fisher Scientific) 
washed with RNA Pulldown Buffer (1X PBS, 0.1% Triton X-100, 0.6 mM PMSF, Roche Complete Protease Inhibitor 
Cocktail) and incubated with rotation at 4°C for 1 h. 1 g of in vitro-transcribed RNAs was heated at 90°C for 2 min and then 
placed on ice for 2 min. An equal volume (10 l) of RNA structure buffer (20 mM Tris-HCl [pH 7.4], 0.2 M KCl, 20 mM 
MgCl2) was added and placed at room temperature for 20 min. RNA was then mixed with washed 50l Dynabeads M-280–
Streptavidin and rotated at 4°C for 1 h. The conjugated beads were then washed five times with cold RNA pulldown buffer 
and incubated with precleared CE in rotation at 4°C for 3 h. Finally, proteins were eluted at 95°C for 5 min in Laemmli sample 
buffer and load on SDS-PAGE gels. 
Immunofluorescence 
Cells were fixed in 4% paraformaldehyde, permeabilized with 0.3% triton in PBS, blocked, and incubated with a primary 
rabbit polyclonal anti-SIRT1 (Millipore) and mouse monoclonal anti-LAMIN B1 (B10, Santa Cruz), both diluted 1:200, and 
detected using Alexa Fluor 594- or 647-conjugated secondary antibodies (1:500; Life Technology). Cells were visualized 
using confocal fluorescence microscopy. 
3D Modelling 
Strings & Binders modelling of the Nkx2-5 locus: Three-dimensional (3D) conformations of the Nkx2-5 locus were 
reconstructed using the SBS polymer chromatin model (Barbieri et al., 2012), which quantitatively describes the biological 
scenario where chromatin contacts are mediated by proteins, such as TFs, which can bind multiple chromatin sites 
simultaneously and, thus, bridge them together. Chromatin filaments are represented as self-avoiding chains of beads, some 
of which are binding sites for specific, diffusing particles named binders. If the binder concentration c and the bead-binder 
interaction energy Eint are above threshold, stable contacts can be formed and the system undergoes coil-globule phase 
transition. In general, binding sites can be of different types, each interacting with its specific, cognate binders. Schematically, 
different binding sites can be visualized as different colours, as shown in Figure 4A. Bead−binder interaction of the same 
colour drives the folding of the chain. The SBS model for the Nkx2-5 locus, i.e. the optimal number of different types of 
binding sites and their arrangement along the polymer, were inferred with the PRISMR learning algorithm (Bianco et al., 
2018). Briefly, PRISMR uses as its only input a contact map of the locus of interest, such as Hi-C, and iteratively finds the 
polymer that minimizes the distance between the input and model contact map. Here, we employed Hi-C data from (Rosa-
Garrido et al., 2017) at 5kb resolution to model a 200kb region around the Nkx2-5 gene (mm10, chr17:26740000-26945000) 
in mouse CMs. The optimal polymer model inferred by our procedure was made up of 615 beads and included 15 different 
binding site types (Figure 4D). 
Polymer model simulations: An ensemble of equilibrium 3D conformations of our polymer model was generated by massive 
parallel molecular dynamics (MD) simulations performed with the freely available LAMMPS software (Plimpton, 1995). The 
SBS polymer is initialized in a self-avoiding walk (SAW) conformation, with binders randomly placed in the surrounding 
environment. The simulation is performed in a cubic box with linear side as long as at least twice the gyration radius of the 
polymer SAW conformation. Periodic boundary conditions were implemented to reduce finite size effects. Starting from its 
 
initial conformation, the system (i.e. beads and binders) evolves by Langevin dynamics, with standard interaction potentials 
described in classical polymer physics studies (Kremer and Grest, 1990) and widely employed in the field (Annunziatella et 
al., 2018). 
The main system parameters are the binder concentration c and binding interaction energy E int. The values for c and Eint were 
set to ensure the coil-globule transition (Chiariello et al., 2016), in order to achieve thermodynamically stable conformations. 
In particular, we employed c ~0.02% (expressed in volume fraction) and Eint = 8.1KBT, in line with previous studies (Barbieri 
et al., 2017; Chiariello et al., 2016). Starting from the SAW conformations, the system evolved up to 2x108 simulation time-
steps, so to reach thermodynamic equilibrium where the polymer is completely folded. The complete ensemble of 
configurations consists of equilibrium structures obtained from 102 independent simulations. Figure 4C shows a typical model 
conformation of the Nkx2-5 locus obtained from an MD simulation. 
Contact maps and correlation metrics: From the generated ensemble of 3D polymers, we computed the average contact 
map for the SBS model (Figure 4B) as the probability of contact between each pair of polymer beads i and j, by considering 
them in contact if their Euclidean distance ri,j was below a threshold (Chiariello et al., 2016). To compare Hi-C and model 
contact maps of the Nkx2-5 locus, we employed the Pearson correlation coefficient, r, and the distance-corrected correlation, 
r' (Bianco et al., 2018). r' is introduced to avoid the trivial contribution of the decaying trend of the contact probability as a 
function of the genomic distance. It is computed as the Pearson correlation coefficient between experimental and model 
matrices obtained by replacing each matrix element (i,j) with its relative variation with respect to the average contact 
probability at the genomic distance |i-j|. 
Comparison of the model binding sites tracks with epigenetic marks: To investigate the biological nature of the model’s 
inferred binding sites, we compared them with available ChIP-seq peaks of histone marks (Papait et al., 2013b) and CTCF 
(Rosa-Garrido et al., 2017). To this aim, we binned the ChIP-seq tracks at 5kb resolution and computed Pearson correlation 
coefficients between each binding site and epigenetic track pair (Bianco et al., 2018) (Figure 4D). Next, we tested the statistical 
significance of the obtained correlations by comparing them against a random control model. We built the control model as a 
distribution of correlations between ChIP-seq data and randomized binding sites tracks (103 independent realizations), 
obtained by bootstrapping the original binding sites positions (Bianco et al., 2018). We considered as significant the 
correlations falling below the 10th percentile (negative correlations) and above the 90th percentile (positive correlations) of the 
random control distribution. Resulting significant correlations are given in Figure 4D. 
Modelling the impact of the eRNA on folding: To test in silico the impact of the eRNAs on 3D folding, we implemented 
the observed decrease in acetylation after IRENE-SS silencing. To this aim, the wild-type (wt) model binding sites which 
correlate with H3K27ac, i.e. types 7 (light blue) and 9 (purple) of Figure 4D were made inert (i.e. converted in non-interacting, 
grey beads) in the two 5kb windows containing the eRNAs and the enhancer (chr7:2674105000-2674115000). Next, the 
model contact matrix was re-computed and compared with the wt Hi-C by measuring distance-corrected correlation r' 
(silenced). To speed up computation, we used the mean-field approximation of the model contact matrices described in 
(Bianco et al., 2018). Notably, after silencing we found a significant correlation decrease, ∆r' = r'(wt)-r'(silenced), in the Nkx2-
5 TAD region (green area in the 3D colour scheme of Figure 4E), statistically higher than the correlation decrease found in a 
control model built by silencing in turn all other possible bins pairs (105 pairs in total) within the region, excluding bins 
containing CTCF sites (Figure 4E, empirical P-value <1/1050.01). A subtraction map between the silenced and wt model 
contact matrices (silenced - wt) was also produced to highlight the contact changes around the silenced region (Figure 4F). In 
particular, the model predicts a reduction of the contact frequency between the gene and enhancer region (dashed box in 
Figure 4F) of ~30% with respect to the wild type. 
Statistical Analysis 
Unpaired t-test was used for two-group comparisons, and ordinary one-way ANOVA for multiple comparisons. Statistical 
analyses were performed with GraphPad Prism 8 software on at least two or three independent experiments, and two-sided P-
value calculated (*, P<0.05; **, P<0.01; ***P<0.001). Data are represented as mean ± standard deviation (SD).
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